Assenagon Asset Management S.A. Ptc Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 631,622 shares of PTCT stock, worth $30.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

631,622

Previous 337,960 86.89%

Holding current value

$30.2 Million

Previous $17.2 Million 79.12%

% of portfolio

0.05%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	BUY	$36.19 - $52.13 $10.6 Million - $15.3 Million	293,662 Added 86.89%	631,622 $30.8 Million
Q1 2025 Apr 15, 2025	SELL	$41.81 - $57.17 $4.25 Million - $5.81 Million	-101,710 Reduced 23.13%	337,960 $17.2 Million
Q4 2024 Jan 14, 2025	SELL	$34.99 - $52.07 $1.85 Million - $2.75 Million	-52,794 Reduced 10.72%	439,670 $19.8 Million
Q3 2024 Oct 23, 2024	BUY	$30.39 - $37.66 $3.64 Million - $4.51 Million	119,637 Added 32.09%	492,464 $18.3 Million
Q2 2024 Jul 18, 2024	BUY	$24.69 - $40.12 $1.64 Million - $2.67 Million	66,596 Added 21.75%	372,827 $11.4 Million
Q1 2024 Apr 24, 2024	BUY	$24.15 - $31.95 $1.54 Million - $2.03 Million	63,570 Added 26.2%	306,231 $8.91 Million
Q4 2023 Jan 17, 2024	BUY	$18.07 - $29.37 $3.44 Million - $5.6 Million	190,628 Added 366.36%	242,661 $6.69 Million
Q3 2023 Nov 06, 2023	BUY	$22.41 - $41.99 $1.04 Million - $1.94 Million	46,247 Added 799.29%	52,033 $1.17 Million
Q2 2023 Jul 25, 2023	SELL	$40.4 - $59.1 $536,956 - $785,498	-13,291 Reduced 69.67%	5,786 $235,000
Q1 2023 Apr 18, 2023	SELL	$38.16 - $48.86 $5.87 Million - $7.52 Million	-153,861 Reduced 88.97%	19,077 $924,000
Q4 2022 Jan 12, 2023	BUY	$33.53 - $54.79 $1.47 Million - $2.4 Million	43,716 Added 33.83%	172,938 $6.6 Million
Q3 2022 Oct 27, 2022	BUY	$41.85 - $53.85 $5 Million - $6.44 Million	119,593 Added 1242.01%	129,222 $6.49 Million
Q2 2022 Jul 27, 2022	SELL	$25.6 - $45.23 $2.59 Million - $4.58 Million	-101,279 Reduced 91.32%	9,629 $386,000
Q1 2022 Apr 25, 2022	BUY	$33.33 - $44.6 $3.06 Million - $4.09 Million	91,723 Added 478.1%	110,908 $4.14 Million
Q4 2021 Feb 01, 2022	BUY	$35.36 - $41.86 $678,381 - $803,084	19,185 New	19,185 $764,000
Q2 2021 Jul 15, 2021	SELL	$37.95 - $49.37 $2.75 Million - $3.57 Million	-72,400 Closed	0 $0
Q4 2020 Feb 01, 2021	SELL	$47.96 - $67.64 $9.35 Million - $13.2 Million	-194,900 Reduced 72.91%	72,400 $4.42 Million
Q3 2020 Oct 07, 2020	BUY	$45.41 - $57.07 $12.1 Million - $15.3 Million	267,300 New	267,300 $12.5 Million
Q1 2020 Apr 17, 2020	SELL	$32.37 - $59.36 $3.33 Million - $6.1 Million	-102,737 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$32.22 - $50.07 $3.31 Million - $5.14 Million	102,737 New	102,737 $4.93 Million

Others Institutions Holding PTCT

# of Institutions

287

Shares Held

78.8M

Call Options Held

223K

Put Options Held

156K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.42B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Ptc Therapeutics, Inc. Transaction History